Trial Profile

Investigator-initiated clinical trial (IIT) of ITIL-306 to enroll patients with non-small cell lung cancer (NSCLC)

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 16 May 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

10 May 2024 According to an Instil Bio media release, preparations are underway with collaborator for investigator-initiated trial (IIT) in non-small cell lung cancer with folate receptor.
22 Jan 2024 New trial record
16 Jan 2024 According to an Instil Bio media release, the company plans to initiate this trial in 2024. The company to explore potential transition of ITIL-306 to a US-based CDMO for manufacturing and clinical development primarily at US clinical trial sites.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com